These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9792510)

  • 1. Peptide affinity chromatography of human clotting factor VIII. Screening of the vWF-binding domain.
    Necina R; Amatschek K; Schallaun E; Schwinn H; Josic D; Jungbauer A
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 715(1):191-201. PubMed ID: 9792510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for the C2 domain of factor VIII in binding to von Willebrand factor.
    Saenko EL; Shima M; Rajalakshmi KJ; Scandella D
    J Biol Chem; 1994 Apr; 269(15):11601-5. PubMed ID: 7512568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor VIII binds to von Willebrand factor via its Mr-80,000 light chain.
    Hamer RJ; Koedam JA; Beeser-Visser NH; Bertina RM; Van Mourik JA; Sixma JJ
    Eur J Biochem; 1987 Jul; 166(1):37-43. PubMed ID: 3109914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topography of the human factor VIII-von Willebrand factor complex.
    Fay PJ; Smudzin TM
    J Biol Chem; 1990 Apr; 265(11):6197-202. PubMed ID: 2108154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synthetic factor VIII peptide of eight amino acid residues (1677-1684) contains the binding region of an anti-factor VIII antibody which inhibits the binding of factor VIII to von Willebrand factor.
    Foster PA; Fulcher CA; Houghten RA; Zimmerman TS
    Thromb Haemost; 1990 Jun; 63(3):403-6. PubMed ID: 2119526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction between human blood-coagulation factor VIII and von Willebrand factor. Characterization of a high-affinity binding site on factor VIII.
    Leyte A; Verbeet MP; Brodniewicz-Proba T; Van Mourik JA; Mertens K
    Biochem J; 1989 Feb; 257(3):679-83. PubMed ID: 2494987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of multimerization of human and recombinant von Willebrand factor on platelet aggregation, binding to collagen and binding of coagulation factor VIII.
    Fischer BE; Kramer G; Mitterer A; Grillberger L; Reiter M; Mundt W; Dorner F; Eibl J
    Thromb Res; 1996 Oct; 84(1):55-66. PubMed ID: 8885147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of human factor VIII and interaction with von Willebrand factor. An electron microscopic study.
    Heijnen HF; Koedam JA; Sandberg H; Beeser-Visser NH; Slot JW; Sixma JJ
    Eur J Biochem; 1990 Dec; 194(2):491-8. PubMed ID: 2125268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of recombinant human B-domain-deleted factor VIII using anti-factor VIII monoclonal antibody selected by the surface plasmon resonance biosensor.
    Oh HK; Lee JM; Byun TH; Park SY; Kim YH
    Biotechnol Prog; 2001; 17(6):1119-27. PubMed ID: 11735450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. von Willebrand factor contributes to longer half-life of PEGylated factor VIII in vivo.
    Tang L; Leong L; Sim D; Ho E; Gu JM; Schneider D; Feldman RI; Monteclaro F; Jiang H; Murphy JE
    Haemophilia; 2013 Jul; 19(4):539-45. PubMed ID: 23534820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of the factor VIII-von Willebrand factor complex directly from plasma by gel filtration.
    Kaersgaard P; Barington KA
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 715(2):357-67. PubMed ID: 9792522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunogenic region within residues Val1670-Glu1684 of the factor VIII light chain induces antibodies which inhibit binding of factor VIII to von Willebrand factor.
    Foster PA; Fulcher CA; Houghten RA; Zimmerman TS
    J Biol Chem; 1988 Apr; 263(11):5230-4. PubMed ID: 2895765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. To serve and protect: The modulatory role of von Willebrand factor on factor VIII immunogenicity.
    Hartholt RB; van Velzen AS; Peyron I; Ten Brinke A; Fijnvandraat K; Voorberg J
    Blood Rev; 2017 Sep; 31(5):339-347. PubMed ID: 28716211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lectin activity of the coagulation factor VIII/von Willebrand complex.
    Santizo F; Zenteno E; Pina-Canseco S; Hernandez-Cruz P; Cruz MM; Mayoral LP; Pérez-Campos E; Martínez-Cruz R
    Tohoku J Exp Med; 2009 Mar; 217(3):209-15. PubMed ID: 19282656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfation of Tyr1680 of human blood coagulation factor VIII is essential for the interaction of factor VIII with von Willebrand factor.
    Leyte A; van Schijndel HB; Niehrs C; Huttner WB; Verbeet MP; Mertens K; van Mourik JA
    J Biol Chem; 1991 Jan; 266(2):740-6. PubMed ID: 1898735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that a secondary binding and protecting site for factor VIII on von Willebrand factor is highly unlikely.
    Layet S; Girma JP; Obert B; Peynaud-Debayle E; Bihoreau N; Meyer D
    Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):129-37. PubMed ID: 1531749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. von Willebrand factor binds to the surface of dendritic cells and modulates peptide presentation of factor VIII.
    Sorvillo N; Hartholt RB; Bloem E; Sedek M; ten Brinke A; van der Zwaan C; van Alphen FP; Meijer AB; Voorberg J
    Haematologica; 2016 Mar; 101(3):309-18. PubMed ID: 26635035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between factor VIII:Ag and factor VIII in recombinant and plasma-derived factor VIII concentrates.
    Lin Y; Yang X; Chevrier MC; Craven S; Barrowcliffe TW; Lemieux R; Ofosu FA
    Haemophilia; 2004 Sep; 10(5):459-69. PubMed ID: 15357771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pro-polypeptide of von Willebrand factor is required for the formation of a functional factor VIII-binding site on mature von Willebrand factor.
    Leyte A; Voorberg J; Van Schijndel HB; Duim B; Pannekoek H; Van Mourik JA
    Biochem J; 1991 Feb; 274 ( Pt 1)(Pt 1):257-61. PubMed ID: 1900418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional characteristics of the B-domain-deleted recombinant factor VIII protein, r-VIII SQ.
    Sandberg H; Almstedt A; Brandt J; Gray E; Holmquist L; Oswaldsson U; Sebring S; Mikaelsson M
    Thromb Haemost; 2001 Jan; 85(1):93-100. PubMed ID: 11204595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.